Regeneron Pharmaceuticals has confirmed its acquisition of 23andMe’s DNA testing business – ensuring customers they will continue to offer the popular DNA service and adopt the company’s standing privacy policies to safeguard customer data. While it’s common for customer data to transfer due to an Continue Reading
From our base in New York, we represent a diverse range of clients across the country and around the world.